⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VCYT News
Veracyte, Inc.
Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026
globenewswire.com
VCYT
Veracyte Secures Medicare Reimbursement for Prosigna Breast Risk of Recurrence Test
globenewswire.com
VCYT
Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026
globenewswire.com
VCYT
Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation
globenewswire.com
VCYT
Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026
globenewswire.com
VCYT
Form 8-K
sec.gov
VCYT
Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform
globenewswire.com
VCYT
Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
globenewswire.com
VCYT
Form 8-K
sec.gov
VCYT
Veracyte Announces Second Quarter 2026 Financial Results
globenewswire.com
VCYT